Impact of sinus surgery in people with cystic fibrosis and chronic rhinosinusitis in the era of highly effective modulator therapy: Protocol for a prospective observational study

PLoS One. 2024 Sep 26;19(9):e0310986. doi: 10.1371/journal.pone.0310986. eCollection 2024.

Abstract

Introduction: Cystic fibrosis (CF) is commonly complicated by chronic rhinosinusitis (CRS). Despite highly effective management options, CRS in people with CF (PwCF+CRS) may be refractory to medical therapy, eventually requiring endoscopic sinus surgery. The impact of sinus surgery on pulmonary, quality of life (QOL), and other outcomes in PwCF+CRS in the expanding era of highly effective modulator therapy has not been fully elucidated. This study aims to determine if endoscopic sinus surgery can offer superior outcomes for PwCF+CRS when compared to continued medical treatment of CRS.

Methods and analysis: This multi-institutional, observational, prospective cohort study will enroll 150 adults with PwCF+CRS across nine US CF Centers who failed initial medical therapy for CRS and elected to pursue either endoscopic sinus surgery or continue medical treatment. To determine if sinus surgery outperforms continued medical therapy in different outcomes, we will assess changes in pulmonary, CF-specific QOL, CRS-specific QOL, sleep quality, depression, headache, cognition, olfaction, productivity loss, and health utility value after treatment. The influence of highly effective modulator therapy on these outcomes will also be evaluated. This study will provide crucial insights into the impact of endoscopic sinus surgery for PwCF+CRS and aid with development of future treatment pathways and guidelines.

Ethics and dissemination: This study has been approved by each institution's internal review board, and study enrollment began August 2019. Results will be disseminated in conferences and peer-reviewed journals.

Trial registration: This study was registered on ClinicalTrials.gov (NCT04469439).

Publication types

  • Observational Study
  • Multicenter Study

MeSH terms

  • Adult
  • Chronic Disease
  • Cystic Fibrosis* / complications
  • Cystic Fibrosis* / surgery
  • Endoscopy
  • Female
  • Humans
  • Male
  • Observational Studies as Topic
  • Paranasal Sinuses / surgery
  • Prospective Studies
  • Quality of Life*
  • Rhinitis* / surgery
  • Rhinosinusitis
  • Sinusitis* / surgery
  • Treatment Outcome

Associated data

  • ClinicalTrials.gov/NCT04469439

Grants and funding

This work was supported by the Cystic Fibrosis Foundation (BESWIC20A0, BESWIC22Y5; https://www.cff.org/) awarded to DMB. This foundation provided support for the planning and execution of this work but did not have specific involvement in the study design, data collection, analysis, or interpretation, or decision to submit the article for publication. CML received grant support from the National Institute on Deafness and Other Communication Disorders of the National Institutes of Health under Award Number R25DC020151 (https://www.nidcd.nih.gov/). The NIH did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. JAA, TEB, JCM, and TLS have received grant support from the Cystic Fibrosis Foundation related to this work in the past 36 months (BESWIC20A0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.